Surrozen (SRZN)
Develops multifunctional Wnt-mimetic biologics for serious retinal vascular and inflammatory eye diseases.
$23.79
Pre-market+1.22 (+5.41%)
At close$22.57(+1.67%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions58 holders · as of Mar 31, 2026 | 76.00% | 8.93M shares | |
| Insiders6 holders · as of Jun 16, 2026 | 17.60% | 2.07M shares | |
| Strategic holders3 holders · as of Jul 24, 2026 | 15.16% | 1.78M shares | |
| Adds to | 108.76% |
11.75M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (11.75M in the company's Sep 3, 2026 report, 7.48M elsewhere); stakes use the report.
These groups come from separate filings that can overlap, so they add to 108.76%; nothing is left for Other.
Institutions13F, as of Mar 31, 2026
58 holders · 8.93M shares · 15 new positions · 32 increased · 13 reduced · 11 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 1.47M | 12.53% | +1.47Mnew | May 15, 2026 |
| Boxer Capital Management, LLC | 766.3K | 6.52% | +350.2K | May 15, 2026 |
| Millennium Management LLC | 731.1K | 6.22% | +9.9K | May 15, 2026 |
| VR Adviser, LLC | 632.9K | 5.39% | 0 | May 15, 2026 |
| Stempoint Capital LP | 525.6K | 4.47% | −94.1K | May 18, 2026 |
| Spruce Street Capital LP | 432.0K | 3.68% | 0 | May 14, 2026 |
| Braidwell LP | 396.1K | 3.37% | −73.9K | May 15, 2026 |
| 5Am Venture Management, LLC | 387.5K | 3.30% | 0 | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Tim Kutzkeyincl. TCG Opportunity III GP, LLC, The Column Group III GP, LP +5 more | 29.30% | 3.82M | 13D | May 18, 2026 ↗ |
| StemPoint Capital Management GP LLCincl. StemPoint Capital LP, Michelle Ross | 12.80% | 427.8K | 13G | Nov 1, 2024 ↗ |
| Venrock Healthcare Capital Partners III, L.P. | 9.90% | 1.21M | 13G | May 15, 2026 ↗ |
| AI Biotechnology LLC | 9.90% | 844.6K | 13G | Mar 31, 2025 ↗ |
| 5AM Partners VII, LLC | 9.50% | 1.16M | 13G | May 15, 2026 ↗ |
| RA Capital Management, L.P. | 9.20% | 871.7K | 13G | Feb 17, 2026 ↗ |
| Integrated Core Strategies (US) LLC | 8.40% | 718.7K | 13G | Feb 5, 2026 ↗ |
| Boxer Capital Management, LLC | 6.67% | 766.3K | 13G | May 15, 2026 ↗ |
| TCG Crossover GP II, LLC | 6.30% | 736.6K | 13G | May 15, 2026 ↗ |
| Braidwell LP | 5.50% | 470.0K | 13G | Feb 17, 2026 ↗ |
| Point72 Asset Management, L.P. | 5.40% | 616.0K | 13G | Apr 23, 2026 ↗ |
| StemPoint Capital LP | 5.00% | 602.8K | 13G | Aug 14, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 22, 2026 | TCG Crossover GP II, LLC10 percent owner | Sale | 162,500 | $21.25 | 574,054 |
| May 4, 2026 | Craig C. Parkerdirector, officer: Chief Executive Officer | Sale | 4,524 | $33.33 | 16,553 |
| May 4, 2026 | Charles O. Williamsofficer: Chief Operating Officer | Sale | 2,036 | $33.33 | 16,571 |
| May 4, 2026 | Yang Liofficer: Exec. Vice President, Research | Sale | 1,584 | $33.33 | 17,216 |
| Mar 23, 2026 | TCG Crossover GP II, LLC10 percent owner | Purchase · 2 lots | 15,223 | $24.90 | 683,225 |
| Mar 24, 2026 | TCG Crossover GP II, LLC10 percent owner | Purchase | 53,329 | $24.69 | 736,554 |
| Mar 12, 2026 | TCG Crossover GP II, LLC10 percent owner | Purchase | 6,187 | $24.99 | 657,301 |
| Mar 13, 2026 | TCG Crossover GP II, LLC10 percent owner | Purchase · 2 lots | 35,433 | $24.88 | 675,018 |
| Mar 16, 2026 | TCG Crossover GP II, LLC10 percent owner | Purchase | 595 | $24.99 | 675,613 |
| Feb 11, 2026 | TCG Crossover GP II, LLC10 percent owner | Purchase · 2 lots | 17,763 | $23.58 | 650,567 |
CongressHouse and Senate disclosures
Not reported.